tiprankstipranks
Trending News
More News >
Coya Therapeutics, Inc. (COYA)
:COYA
US Market

Coya Therapeutics, Inc. (COYA) Income Statement

Compare
66 Followers

Coya Therapeutics, Inc. Income Statement

Last quarter (Q4 2024), Coya Therapeutics, Inc.'s total revenue was $3.55B, an increase of 59053.40% from the same quarter last year. In Q4, Coya Therapeutics, Inc.'s net income was $-2.92M. See Coya Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.55B$ 6.00M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 3.55B$ 5.97M$ -27.36K$ -16.13K$ 0.00
Operating Expenses
$ 20.80B$ 13.91M$ 9.81M$ 4.87M$ 694.77K
Depreciation and Amortization
$ 27.36K$ 27.36K$ 27.36K$ 16.13K$ 704.65K
EBITDA
$ -17.22M$ -7.90M$ -12.22M$ -4.85M$ 10.44K
Operating Income
$ -17.25B$ -7.90M$ -9.81M$ -4.87M$ -694.77K
Other Income/Expenses
$ 3.09B$ 639.37K$ -2.43M$ -21.48K$ -38.43K
Pretax Income
$ -14.16B$ -7.26M$ -12.24M$ -4.89M$ -733.20K
Net Income
$ -14.88M$ -7.99M$ -14.68M$ -4.87M$ -733.20K
Per Share Metrics
Basic EPS
$ -0.98$ -0.79$ -1.48$ -0.50$ -0.08
Diluted EPS
$ -0.98$ -0.79$ -1.48$ -0.50$ -0.08
Weighted Average Shares Outstanding
15.24M 10.16M 9.95M 9.68M 9.68M
Weighted Average Shares Outstanding (Diluted)
15.24M 10.16M 9.95M 9.68M 9.68M
Currency in USD

Coya Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis